In vitro antimicrobial activity of RU-59863, A C-7 catechol substituted cephalosporin

Diagnostic Microbiology and Infectious Disease

Volumn 28, Issue 2, 1997, Pages 93-100

  Erwin, Meridith E ^a   Varnam, David ^a   Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; RU 59863; UNCLASSIFIED DRUG;

ACINETOBACTER; ANTIMICROBIAL ACTIVITY; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; DRUG ACTIVITY; DRUG POTENCY; ENTEROCOCCUS FAECALIS; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STENOTROPHOMONAS MALTOPHILIA;

BACTERIA; CEPHALOSPORINS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0030768089     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00004-7     Document Type: Article

References (15)

1. Aszodi J, Humbert D, Bonnefoy A, Collette P, Mauvais P, Chantot JF (1994a) RU 59863, a novel catechol-substituted vinylogous cephalosporin: In vitro antibacterial activity. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, (abst F 99), p. 161.
2. Aszodi J, Bonnefoy A, Chantot JF (1994b) RU-59863, a novel catechol-substituted vinylogous cephalosporin: In vivo antibacterial activity. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, (abst F 101), p. 161.
3. Bryskier A, Aszodi J, Chantot J-F (1994) Parenteral cephalosporin classification. Expert Opin Invest Drugs 3:145-171.
4. Bush K, Jacoby GA, Medeiros AA (1995) A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39:1211-1233.
5. Curtis NAC, Eisenstadt RL, East SJ, Cornford RJ, Walker LA, White AJ (1988) Iron-regulated outer membrane proteins of Escherichia coli K-12 and mechanism of action of catechol-substituted cephalosporins. Antimicrob Agents Chemother 32:1879-1886.
6. Erwin ME, Jones RN, Barrett MS, Briggs BM, Johnson DM (1991) In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin. Antimicrob Agents Chemother 35:929-937.
7. Jacoby GA, Carreras I (1990) Activity of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 34: 858-862.
8. Jones RN, Erwin ME (1992) In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin. Antimicrob Agents Chemother 36:233-238.
9. Kim MY, Oh JI, Paek KS, Kim YZ, Kim IC, Kwak JH (1996) In vitro and in vivo activities of LB10522, a new catecholic cephalosporin. Antimicrob Agents Chemother 40: 1825-1831.
10. Naas T, Vandel L, Sougakoff W, Livermore DM, Nordmann P (1994) Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A β-lactamase, Sme-1, from Serratia marcescens S6. Antimicrob Agents Chemother 38:1262-1270.
11. National Committee for Clinical Laboratory Standards (NCCLS) (1993) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A3. 3rd ed. Villanova, PA: NCCLS.
12. National Committee for Clinical Laboratory Standards (NCCLS) (1995) Performance standards for antimicrobial susceptibility testing. Sixth information supplement, M100-S6. Villanova PA: NCCLS.
13. Silley P, Griffiths JW, Monsey D, Harris AM (1990) Mode of action of GR69153, a novel catechol-substituted cephalosporin, and its interaction with the tonB-dependent iron transport system. Antimicrob Agents Chemother 34: 1806-1808.
14. Tatsumi Y, Maejima T, Mitsuhashi S (1995) Mechanism of tonB-dependent transport of KP-736, a 1,5-dihydroxy-4-pyridone-substituted cephalosporin, into Escherichia coli K-12 cells. Antimicrob Agents Chemother 39:613-619.
15. Watanabe NA, Nagasu T, Katsu K, Kitoh K (1987) E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the tonB-dependent iron transport system. Antimicrob Agents Chemother 31:497-504.